A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64‐week multinational randomized phase IV study in 1790 patients (PSO‐TOP)
暂无分享,去创建一个
P. Gisondi | K. Reich | E. D. De Jong | U. Mrowietz | R. Warren | L. Puig | H. Bachelez | I. Zschocke | C. Ortland | U. Mrowietz | R. Warren | Kristian Reich | Lluís Puig | E.M.G.J. de Jong | Hervé Bachelez